{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Tc+99m+tilmanocept&page=2", "query": { "intervention": "Tc 99m tilmanocept", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 25, "total_pages": 3, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Tc+99m+tilmanocept&page=3&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Tc+99m+tilmanocept&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-04T00:11:24.289Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02865434", "title": "Evaluating Safety of Escalating Doses of Tilmanocept by IV Injection and SPECT Imaging in Subjects With and Without RA", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Arthritis, Rheumatoid" ], "interventions": [ { "name": "Tc99m-tilmanocept", "type": "DRUG" }, { "name": "SPECT Imaging (60 Minutes post-injection)", "type": "PROCEDURE" }, { "name": "SPECT Imaging (180 Minutes post-injection)", "type": "PROCEDURE" }, { "name": "Whole body planar SPECT imaging (15 Minutes post-injection)", "type": "PROCEDURE" }, { "name": "Whole body planar SPECT imaging (60 Minutes post-injection)", "type": "PROCEDURE" }, { "name": "Whole body planar SPECT imaging (180 Minutes post-injection)", "type": "PROCEDURE" }, { "name": "Whole body planar SPECT imaging (18-20 Hours post-injection)", "type": "PROCEDURE" }, { "name": "Blood Collection for PK Testing (15 Mins Before Injection)", "type": "PROCEDURE" }, { "name": "Blood Collection for PK Testing (after injection)", "type": "PROCEDURE" }, { "name": "Blood Collection for PK Testing (15 minutes post injection)", "type": "PROCEDURE" }, { "name": "Blood Collection for PK Testing (60 minutes post injection)", "type": "PROCEDURE" }, { "name": "Blood Collection for PK Testing (180 minutes post injection)", "type": "PROCEDURE" }, { "name": "Blood Collection for PK Testing (18-20 hours post injection)", "type": "PROCEDURE" }, { "name": "Planar Image with both Hands in Field of View", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "PROCEDURE" ], "sponsor": "Navidea Biopharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 39, "start_date": "2017-01", "completion_date": "2018-06", "has_results": true, "last_update_posted_date": "2021-08-12", "last_synced_at": "2026-10-04T00:11:24.289Z", "location_count": 1, "location_summary": "Kettering, Ohio", "locations": [ { "city": "Kettering", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT02865434" }, { "nct_id": "NCT03938636", "title": "Evaluation of the Precision and Sensitivity of Tilmanocept Uptake Value (TUV) on Tc 99m Tilmanocept Planar Imaging", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Rheumatoid Arthritis" ], "interventions": [ { "name": "Tc 99m tilmanocept", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Navidea Biopharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 116, "start_date": "2019-04-08", "completion_date": "2021-06-30", "has_results": true, "last_update_posted_date": "2023-08-24", "last_synced_at": "2026-10-04T00:11:24.289Z", "location_count": 10, "location_summary": "Scottsdale, Arizona • Los Angeles, California • San Francisco, California + 7 more", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "Los Angeles", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Palmetto Bay", "state": "Florida" }, { "city": "Lincoln", "state": "Nebraska" } ], "official_url": "https://clinicaltrials.gov/study/NCT03938636" }, { "nct_id": "NCT02509585", "title": "A Trial of Comparing the Pathology Status of Lymphoseek®-Identified Sentinel Lymph Nodes Relative to the Pathological Pathology Status of Nonsentinel Lymph Nodes in Nodal Staging of Subjects With Known Cancer of the Cervix Who Are Undergoing Lymph Node Dissection", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Uterine Cervical Neoplasms" ], "interventions": [ { "name": "Tc99m tilmanocept", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Cardinal Health 414, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 18, "start_date": "2016-01", "completion_date": "2017-07", "has_results": true, "last_update_posted_date": "2019-02-11", "last_synced_at": "2026-10-04T00:11:24.289Z", "location_count": 4, "location_summary": "La Jolla, California • Miami, Florida • Winston-Salem, North Carolina + 1 more", "locations": [ { "city": "La Jolla", "state": "California" }, { "city": "Miami", "state": "Florida" }, { "city": "Winston-Salem", "state": "North Carolina" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT02509585" }, { "nct_id": "NCT00911326", "title": "Evaluation of Sentinel Lymph Nodes in Head and Neck Squamous Cell Carcinoma", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Head and Neck Squamous Cell Carcinoma (HNSCC)" ], "interventions": [ { "name": "Lymphoseek", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Navidea Biopharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 101, "start_date": "2009-05", "completion_date": "2013-08", "has_results": true, "last_update_posted_date": "2014-08-08", "last_synced_at": "2026-10-04T00:11:24.289Z", "location_count": 13, "location_summary": "Birminham, Alabama • La Jolla, California • San Diego, California + 10 more", "locations": [ { "city": "Birminham", "state": "Alabama" }, { "city": "La Jolla", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Miami", "state": "Florida" }, { "city": "Kansas City", "state": "Kansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00911326" }, { "nct_id": "NCT04947137", "title": "Development of a Normative Database for Rheumatoid Arthritis (RA) Imaging With Tc99m Tilmanocept", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Rheumatoid Arthritis" ], "interventions": [ { "name": "Tc99m tilmanocept", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Navidea Biopharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 134, "start_date": "2021-05-27", "completion_date": "2022-01-21", "has_results": true, "last_update_posted_date": "2025-01-08", "last_synced_at": "2026-10-04T00:11:24.289Z", "location_count": 7, "location_summary": "Miami Lakes, Florida • Palmetto Bay, Florida • Kettering, Ohio + 4 more", "locations": [ { "city": "Miami Lakes", "state": "Florida" }, { "city": "Palmetto Bay", "state": "Florida" }, { "city": "Kettering", "state": "Ohio" }, { "city": "Tulsa", "state": "Oklahoma" }, { "city": "Duncansville", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT04947137" }, { "nct_id": "NCT02683421", "title": "Evaluation of SC Injected Tc 99m Tilmanocept Localization in Active RA Subjects by SPECT and SPECT/CT Imaging", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Rheumatoid Arthritis" ], "interventions": [ { "name": "Tilmanocept", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Navidea Biopharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "21 Years", "maximum_age": null, "sex": "ALL", "summary": "21 Years and older" }, "enrollment_count": 18, "start_date": "2016-07", "completion_date": "2016-12", "has_results": true, "last_update_posted_date": "2019-11-21", "last_synced_at": "2026-10-04T00:11:24.289Z", "location_count": 2, "location_summary": "Los Angeles, California • San Francisco, California", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02683421" }, { "nct_id": "NCT02201420", "title": "Evaluation of Tc 99m Tilmanocept Localization in Primary Cutaneous Kaposi's Sarcoma and Lymphatic Drainage by SPECT/CT", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Kaposi's Sarcoma" ], "interventions": [ { "name": "Tc 99m tilmanocept", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Navidea Biopharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 5, "start_date": "2014-09", "completion_date": "2015-10", "has_results": true, "last_update_posted_date": "2016-09-27", "last_synced_at": "2026-10-04T00:11:24.289Z", "location_count": 1, "location_summary": "San Francisco, California", "locations": [ { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02201420" }, { "nct_id": "NCT03405142", "title": "Panitumumab-IRDye800 Compared to Sentinel Node Biopsy and (Selective) Neck Dissection in Identifying Metastatic Lymph Nodes in Patients With Head&Neck Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Head and Neck Squamous Cell Carcinoma", "Squamous Cell Carcinoma of the Head and Neck (SCCHN)", "Head and Neck Cancer" ], "interventions": [ { "name": "Panitumumab-IRDye800", "type": "DRUG" }, { "name": "Lymphoseek", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eben Rosenthal", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "19 Years", "maximum_age": null, "sex": "ALL", "summary": "19 Years and older" }, "enrollment_count": 3, "start_date": "2019-08-01", "completion_date": "2021-04-27", "has_results": true, "last_update_posted_date": "2022-11-10", "last_synced_at": "2026-10-04T00:11:24.289Z", "location_count": 1, "location_summary": "Palo Alto, California", "locations": [ { "city": "Palo Alto", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03405142" }, { "nct_id": "NCT07121595", "title": "Personalized Neck Radiation Therapy Directed by Sentinel Lymph Node Biopsy for the Treatment of Oral Cavity Squamous Cell Carcinoma, PRECEDENT Trial", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Oral Cavity Squamous Cell Carcinoma", "Stage I Lip and Oral Cavity Cancer AJCC v8", "Stage II Lip and Oral Cavity Cancer AJCC v8", "Stage III Lip and Oral Cavity Cancer AJCC v8", "Stage IVA Lip and Oral Cavity Cancer AJCC v8" ], "interventions": [ { "name": "Biospecimen Collection", "type": "PROCEDURE" }, { "name": "Carboplatin", "type": "DRUG" }, { "name": "Cisplatin", "type": "DRUG" }, { "name": "Computed Tomography", "type": "PROCEDURE" }, { "name": "Modified Barium Swallow", "type": "PROCEDURE" }, { "name": "Paclitaxel", "type": "DRUG" }, { "name": "Positron Emission Tomography", "type": "PROCEDURE" }, { "name": "Questionnaire Administration", "type": "OTHER" }, { "name": "Radiation Therapy", "type": "RADIATION" }, { "name": "Sentinel Lymph Node Biopsy", "type": "PROCEDURE" }, { "name": "Single Photon Emission Computed Tomography", "type": "PROCEDURE" }, { "name": "Technetium Tc 99m-labeled Tilmanocept", "type": "RADIATION" }, { "name": "Technetium Tc-99m Sulfur Colloid", "type": "OTHER" } ], "intervention_types": [ "PROCEDURE", "DRUG", "OTHER", "RADIATION" ], "sponsor": "University of Michigan Rogel Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 50, "start_date": "2025-07-17", "completion_date": "2030-07-01", "has_results": false, "last_update_posted_date": "2026-07-31", "last_synced_at": "2026-10-04T00:11:24.289Z", "location_count": 1, "location_summary": "Ann Arbor, Michigan", "locations": [ { "city": "Ann Arbor", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT07121595" }, { "nct_id": "NCT03157167", "title": "An Evaluation of Tc 99m Tilmanocept by Intravenous (IV) and Subcutaneous (SC) Injection in Kaposi Sarcoma (KS)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Kaposi Sarcoma", "HIV Infections" ], "interventions": [ { "name": "Tc99m-tilmanocept", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Navidea Biopharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 15, "start_date": "2017-12-01", "completion_date": "2020-03-30", "has_results": true, "last_update_posted_date": "2025-03-05", "last_synced_at": "2026-10-04T00:11:24.289Z", "location_count": 1, "location_summary": "San Francisco, California", "locations": [ { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03157167" } ] }